Obstacles and Advances in Anemia Management in Patients With CKD

Slides:



Advertisements
Similar presentations
Update of Anemia management in chronic kidney disease What is still missing.
Advertisements

Anemia an enigma in chronic kidney disease Mohammad Asgar Khan, MD.
Anemia in chronic kidney disease
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Marilyn Telen, MD Duke University
NKF-KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease UPDATE OF HEMOGLOBIN TARGET Am.J.Kidney.Dis.
Dr. Mohamed M. Ghanem. Definition A deficiency in iron results in the development of anemia (lower than normal number of red blood cells). In iron deficiency.
Anemia in Hemodialysis 1. 2 Etiology The anemia of chronic kidney disease (CKD) is primarily due to insufficient production of the glycoprotein hormone.
Vitamin D deficiency and anemia in early chronic kidney disease 2010/05/18 R4 이완수 2010.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
httpwww.youtube.com/watch?v=DhxD6sVQEYc:// The Drug Discovery Process.
Updates From Kidney Week Chronic Kidney Disease and Associated Anemia
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
Medical Directorate, National Kidney Foundation, Singapore
Mansoura International Hospital Mansoura International Hospital
Hypothesis: an erythropoietin honeymoon phase exists
Algorithm for management of anemia of CKD in adults
Iron deficiency anemia. (Peripheral blood, 50 ×
Claudia Beals, MD John Detesco Erdal Sarac, MD FACP FASN
The Nurse View: Management of Pancreatic Cancer
Figure 1. Comparison of salivary superoxide dismutase (SOD), activity (%) between the control group (CG) and the test groups (periodontally healthy iron.
Algorithm for iron therapy in management of anemia of CKD
Locatelli et al. Am J Nephrol 2017;45:   (DOI: / )
Volume 88, Issue 5, Pages (November 2015)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD  Nupur Gupta, MD, Jay B. Wish, MD  American.
A Multidisciplinary Team Approach Challenges and Best Practices in Cushing Disease.
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Advancing Management of Anemia With the Latest Data From ERA-EDTA 2018
New and Emerging Management Options for Anemia in CKD
Introduction to Checkpoint Inhibitors
New options for the anemia of chronic kidney disease
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.
Addressing Iron Deficiency in Chronic HF
Iron Deficiency Anemia
American Journal of Kidney Diseases 
Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A
A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients.
Forming Effective Individualized Treatment Plans for Patients With Low-Risk MDS.
Volume 88, Issue 5, Pages (November 2015)
Volume 90, Issue 5, Pages (November 2016)
Immunotherapy for cSCC
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Iron Deficiency Anemia
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD  Nupur Gupta, MD, Jay B. Wish, MD  American.
When Is Intrathecal Drug Delivery Appropriate?
Managing CKD-Associated Anemia in Challenging Patients
Implications of Emerging Treatments for Beta-Thalassemia
EGPA.
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Chapter 4: Red cell transfusion to treat anemia in CKD
Iron Deficiency in Heart Failure
Challenges in LA SCCHN.
How Can Precision Medicine in Oncology Refine Best Treatment Approach?
Background. Current Perspectives on the Management of Iron Deficiency in Chronic Heart Failure.
Volume 86, Issue 1, Pages (July 2014)
Clinical Decision Support In Action: Back Pain/Surgery
When Is Intrathecal Drug Delivery Appropriate?
Volume 68, Issue 6, Pages (December 2005)
The FAIR-HF Trial Reference
Francesco Locatelli, Lucia Del Vecchio  Kidney International 
Niels Grote Beverborg et al. JCHF 2018;6:
Anemia Explored.
Challenges and Emerging Solutions in Anemia Management Explored
Widening the Options for Major Depressive Disorder
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
Schematic representation of the mechanisms underlying anemia of CKD
Ask the Psoriasis Expert
Comprehensive Acne Management
Presentation transcript:

Obstacles and Advances in Anemia Management in Patients With CKD

Introduction

Etiology of Anemia in CKD

Diagnosis and Evaluation of Anemia

Initial Evaluation of Anemia in a Patient With CKD

Classification of Iron Deficiency in CKD

Target Hemoglobin and Iron Indices

Treatment Options IV Iron and ESAs

Challenges With Conventional Iron Formulations

Effects of Ferric Citrate Effects of Ferric Citrate* in the Treatment of Iron Deficiency Anemia in Patients With NDD-CKD

Role of HIF and HIF-PH in Erythropoiesis

Roxadustat (FG-4592)* Effects on Hepcidin

Emerging HIF-PH Inhibitors* Most Recent Trial Results

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.